Clinical outcomes between calcium channel blockers and angiotensin receptor blockers in hypertensive patients without established cardiovascular diseases during a 3-year follow-up
Abstract Although both angiotensin receptor blockers (ARBs) and dihydropyridine calcium channel blockers (CCBs) are all suitable for the initiation of antihypertensive treatment, studies investigating efficacy and safety between ARBs and CCBs are limited, and there is no previous study comparing the...
Guardado en:
Autores principales: | Han Saem Jeong, Hong‐Seok Lim, Hun-Jun Park, Wang-Soo Lee, Jin-Oh Choi, Hui Seung Lee, Sang-Ho Jo, Soon Jun Hong |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/496695593ae64872a6cbb06e900c011d |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Herbicidal properties of antihypertensive drugs: calcium channel blockers
por: Hannan Safiyyah Tan Sian Hui Abdullah, et al.
Publicado: (2021) -
Usage of Angiotensin-Converting Enzyme Inhibitor or Angiotensin II Receptor Blocker in Hypertension Intracerebral Hemorrhage
por: Zhang C, et al.
Publicado: (2021) -
Addition of a renin-angiotensin-aldosterone system inhibitor to a calcium channel blocker ameliorates arterial stiffness
por: Kiuchi S, et al.
Publicado: (2015) -
Adenosine modulators and calcium channel blockers as add-on treatment for schizophrenia
por: Jonne Lintunen, et al.
Publicado: (2021) -
Effect of calcium channel blockers on incidence of diabetes: a meta-analysis
por: Noto H, et al.
Publicado: (2013)